Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
01 May, 2026, 11.26 AM IST
Dr Reddy's gets 2 observations from USFDA for Telangana API plantDr. Reddy's Laboratories received a Form 483 with two observations following a GMP inspection by the USFDA at its API manufacturing plant (...
25 May, 2025, 02.42 PM IST
No observations by US FDA during plant inspection: DRLDr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) ins...
21 Sep, 2024, 12.14 AM IST
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plantBiocon Biologics received EMA approval to manufacture biosimilar Bevacizumab in Bengaluru, providing additional capacity to address patient...
24 Jun, 2024, 11.43 AM IST
Biocon gets 4 observations from USFDA for Andhra Pradesh facilityBiocon received four observations from the US health regulator after a GMP inspection at its API facility in Andhra Pradesh.
22 Jun, 2024, 07.23 PM IST
USFDA issues Form 483 with five observations to Torrent Pharma unitTorrent Pharmaceuticals announced that the US Food and Drug Administration (USFDA) issued a Form 483 with five observations after inspectin...
12 Jun, 2024, 10.43 PM IST
USFDA warns Cipla for lapses in manufacturing practices at Pithampur facilityAccording to an exchange filing, the drug manufacturer was given a detailed breakdown of the lapses in methods followed at the facility by ...
20 Nov, 2023, 08.30 AM IST
Dr Reddy's clears USFDA inspection for two plantsDr Reddy's said it has received establishment inspection report (EIR) for its formulations manufacturing unit in Srikakulam (FTO SEZ PU2), ...
17 Jun, 2023, 11.45 AM IST
Cipla's Pithampur unit gets 8 observations from USFDA after inspectionThe US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facilit...
18 Feb, 2023, 07.35 PM IST
Strides Pharma Science's Puducherry facility successfully completes EU GMP inspectionThe inspection was carried out on April 28, 2021 and the company has now received the renewed GMP (Good Manufacturing Practices) certificat...
28 Jun, 2021, 12.51 PM IST
Biocon gets EIR from USFDA for manufacturing facility in BengaluruBiocon on Friday said it has received the establishment inspection report (EIR) from US health regulator for the post-approval and good man...
20 Mar, 2020, 12.06 PM IST
USFDA issues Form 483 with 5 observations to Biocon's Bengaluru facilityAs per the USFDA, a Form 483 is issued to Biocon's management at the conclusion of an inspection when investigator has observed any conditi...
27 Jan, 2020, 11.23 AM IST
UK regulator reinstates full GMP status of Indoco Remedies Goa facilityWith this development, the company's operations in Europe will now take off on a fast-track, Indoco Remedies MD Aditi Panandikar said.
13 Sep, 2019, 02.00 PM IST
Sun Pharma gets 3 observations from USFDA for Halol plantThe United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol f...
23 Feb, 2018, 07.12 PM IST
ANSM gives GMP nod to Biocon, to re-inspect drug product unitBiocon, with its partner Mylan, will work with the French and European regulatory authorities with regard to the follow- up inspection of t...
09 Jul, 2017, 07.13 PM IST
Wockhardt's Chikalthana plant gets GMP certificate from UKMHRAIn a major relief to drug firm Wockhardt, its Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice cer...
01 Dec, 2015, 09.16 PM IST
EU lifts drug export ban from Ranbaxy's Toansa plantThe assessment of the Toansa facility by EMA followed an inspection by the USFDA, which revealed areas of non-compliance with GMP at the si...
05 Jun, 2014, 08.23 PM IST